We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Mixed Reality Software Device Enables Surgeons to Plan Complex Procedures Using Immersive 3D Holographic Technology

By HospiMedica International staff writers
Posted on 06 Dec 2022
Print article
Image: A chief of visceral surgery visualizes 3D holograms in medical mixed reality (Photo courtesy of apoQlar)
Image: A chief of visceral surgery visualizes 3D holograms in medical mixed reality (Photo courtesy of apoQlar)

The third-leading cause of death globally is surgeries plus 30 days post operative care. This is more than HIV, malaria and tuberculosis combined. 50% of surgical adverse events happen due to human error. Surgeons across all medical fields experience the same problem because they can’t plan for what they can’t see and have limited support in the operating room. Now, that could change with a pioneering mixed reality software device that enables surgeons to plan complex procedures using the power of immersive 3D holographic technology.

VSI HoloMedicine from apoQlar GmbH (Hamburg, Germany) is a medically certified software platform that leverages the Microsoft HoloLens 2 hardware to transform medical images, clinical workflows and medical education into a 3D mixed reality environment the world has never seen before. VSI HoloMedicine gives surgeons an almost "X-ray vision" perspective in surgical planning processes using 3D holographic technology. Physicians across any medical field can now plan surgeries in 3D and visualize medical data inside or outside of the operating room. Using Microsoft's HoloLens 2, a mixed reality head-mounted display (HMD), surgeons can transform otherwise flat CT, Angio CT, MRI, CBCT, PET, and SPECT sources into interactive 3D holograms. apoQlar has received FDA 510(k) Class II clearance for VSI HoloMedicine and now plans to scale VSI Holomedicine as the foundation of modern surgical care.

"With mixed reality, we are no longer bound to physical objects in a physical world. We can leverage digital objects and services on top of the real world for equal or greater utility and usually at a fraction of the cost. Mixed Reality is a completely new way for people, and in our case surgeons, physicians and technologists, to continue to experience the real world around them but with an entire virtual layer placed on top" said Sirko Pelzl, Co-Founder & CEO of apoQlar.

Related Links:
apoQlar GmbH 

Gold Member
12-Channel ECG
CM1200B
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Neonatal Ventilator
Servo-n

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.